Citadel Advisors’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-18,891
| Closed | -$40K | – | 5315 |
|
|
2018
Q3 | $40K | Sell |
18,891
-664
| -3% | -$1.41K | ﹤0.01% | 4031 |
|
|
2018
Q2 | $45K | Sell |
19,555
-35,023
| -64% | -$80.6K | ﹤0.01% | 3924 |
|
|
2018
Q1 | $174K | Buy |
54,578
+10,000
| +22% | +$31.9K | ﹤0.01% | 3521 |
|
|
2017
Q4 | $183K | Buy |
44,578
+10,991
| +33% | +$45.1K | ﹤0.01% | 3414 |
|
|
2017
Q3 | $152K | Sell |
33,587
-12,410
| -27% | -$56.2K | ﹤0.01% | 3271 |
|
|
2017
Q2 | $154K | Buy |
+45,997
| New | +$154K | ﹤0.01% | 3223 |
|
|
2017
Q1 | – | Sell |
-18,306
| Closed | -$141K | – | 4598 |
|
|
2016
Q4 | $141K | Buy |
18,306
+5,533
| +43% | +$42.6K | ﹤0.01% | 3178 |
|
|
2016
Q3 | $146K | Buy |
+12,773
| New | +$146K | ﹤0.01% | 3129 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 4400 |
|
|
2016
Q1 | – | Sell |
-5,648
| Closed | -$127K | – | 4578 |
|
|
2015
Q4 | $127K | Buy |
+5,648
| New | +$127K | ﹤0.01% | 3163 |
|
|
2014
Q1 | – | Sell |
-8,953
| Closed | -$264K | – | 3990 |
|
|
2013
Q4 | $264K | Buy |
+8,953
| New | +$264K | ﹤0.01% | 2364 |
|